Day: September 11, 2025
ANNOUNCEMENT NO. 291
11 September 2025Guidance for the 2025/26 financial year 
ChemoMetec today approved the annual report for 2024/25, including the guidance for 2025/26, which is considered inside information.
For 2025/26, ChemoMetec expects revenue in the range of DKK 545-565 million (2024/25: DKK 495.6 million) and EBITDA in the range of DKK 295-315 million (2024/25: DKK 258.0 million).
The annual report for 2024/25, which is released along with this announcement, sets out the underlying assumptions applied in the preparation of the guidance for 2025/26 (p. 39-40).Additional information
Martin Helbo Behrens, CEOTel.: (+45) 48 13 10 20
Kim Nicolajsen, CFOTel.: (+45) 48 13 10 20
About ChemoMetec A/S
ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments...
Vranken-Pommery Monopole : Financial Press Release First-Half 2025 Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
FINANCIAL PRESS RELEASE
FIRST-HALF 2025 RESULTS
A performance that translates into a slight improvement in net incomeConsolidated revenue stable at €109.3m (-0.2%)
+€0.5m increase in Group net incomeReims, September 11, 2025The Board of Directors of Vranken-Pommery Monopole met on September 11, 2025 under the chairmanship of Mrs. Nathalie Vranken, and in the presence of the Statutory Auditors, to approve the Group’s financial statements for the half year 2025.The limited review procedures on the half-year financial statements have been performed by the Statutory Auditors, their report is being issued.Consolidated dataH1 2025 (€m)
H1 2024 (€m)
Var vs H1 24 (€m)
Var vs H1 24 (%)Turnover
109.3
109.6
-0.2
-0.2%Recurring operating income
13.8
15.1
-1.2
-8.0%Operating income
13.7
14.7
-1.1
-7.2%Financial result
-15.3
-16.4
+1.0
 ...
ASUS Listed on TIME’s World’s Best Companies 2025 for the Second Time
Written by Customer Service on . Posted in Public Companies.
The esteemed ranking celebrates ASUS for outstanding performance in employee satisfaction, revenue growth, and sustainable practices
KEY POINTSTIME recognition: ASUS secures its second inclusion on TIME’s World’s Best Companies that set the standard in innovation, growth, employee satisfaction
A commitment to innovation: ASUS validated for its leadership in fostering a great workplace, driving business growth, and advancing sustainability
Global distinction: ASUS continues to receive worldwide acclaim from esteemed organizations like Fortune, Forbes, and NewsweekTORONTO, Sept.  11, 2025  (GLOBE NEWSWIRE) — ASUS today announced its second appearance in TIME magazine’s prestigious list of the World’s Best Companies. This accolade recognizes organizations that set the standard in employee satisfaction, revenue growth, and sustainability...
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2025
Written by Customer Service on . Posted in Public Companies.
Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2025
(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Paris, France (September 11, 2025 – 6:00 pm) – As of August 31, 2025, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below. 
August 31, 2025Shares outstanding
463,145,529Number of real voting rights (excluding treasury shares)
461,157,737Theoretical number of voting rights (including treasury shares)
463,145,529It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula contained in article...
OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED, a Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Nivolumab or Docetaxel in Patients with Non-Small Cell Cancer
Written by Customer Service on . Posted in Public Companies.
OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED, a Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Nivolumab or Docetaxel in Patients with Non-Small Cell CancerA total of 105 HLA-A2 positive patients enrolled in the Combi-TED study, which explores the combination of Tedopi® with either an anti-PD1 checkpoint inhibitor or chemotherapy as a second-line treatment for metastatic Non-Small Cell Lung Cancer following first-line chemo-immunotherapy.
Top-line results expected in the second half of 2026.NANTES, France – ROME, Italy – September 11, 2025, 6:00 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a biotechnology company focused on developing first-in-class therapies in immuno-oncology and immuno-inflammation, and the FoRT Foundation (Fondazione...
Hermès International : Shares and voting rights as of 31st August 2025
Written by Customer Service on . Posted in Public Companies.
RELEASE
Paris, September 11, 2025
INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES COMPRISING THE SHARE CAPITALIn accordance with the provisions of Article L. 233-8 of the French Commercial Code (Code de commerce) and Article 223-16 of the General Regulations of French Autorité des Marchés Financiers (AMF), Hermès international publishes each month, before the 15th day of the following month, the total number of voting rights and the number of shares comprising the share capital if they have varied from those previously published.Date
Total number of shares
Total number of theoretical voting rights (including treasury stock)
Total number of effective voting rights (exercisable at shareholders’ meetings)
Publications31 August 2025
105 569 412
179 545 613
178 811 721
11 September 202531 July 2025
105 569 412
179 550 181
178 816 459
11...
Ipsen – August 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
Written by Customer Service on . Posted in Public Companies.
Monthly information relative to the total number of voting rights and shares composing the share capital
(in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers)
Market: Euronext Paris ISIN Code: FR 0010259150LEI: 549300M6SGDPB4Z94P11Date
Total number of shares composing the share capital
Total number of voting rights (1)31 August 2025
83,814,526
Gross total*   of voting rights: 132,062,873Net total** of voting rights: 130,937,383(1) Existence of a statutory clause imposing an obligation to declare threshold crossing complementary to the one relative to the legal thresholds (Article 10).
* Gross total = total number of voting rights attached to the total number of shares, including the number of shares...
FORVIA FURTHER IMPROVES ITS DEBT PROFILE BY USING THE €600M PROCEEDS FROM ITS NEW SENIOR NOTES DUE 2031 AND AVAILABLE CASH TO REPURCHASE €700M OF BONDS MATURING IN 2027
Written by Customer Service on . Posted in Public Companies.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1993, AS AMENDED (THE “SECURITIES ACT”)) OR ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE US VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.
NANTERRE (FRANCE)SEPTEMBER 11, 2025
FORVIA FURTHER IMPROVES ITS DEBT PROFILE BY USING THE €600M PROCEEDS FROM ITS NEW SENIOR NOTES DUE 2031 AND AVAILABLE CASH TO REPURCHASE €700M OF BONDS MATURING IN 2027
With the success of the cash tender offers for the repurchase of FORVIA’s...
PETROBRAS CHOOSES VALLOUREC TO SUPPORT $1BN OFFSHORE OCTG PROJECTS
Written by Customer Service on . Posted in Public Companies.
PETROBRAS CHOOSES VALLOUREC TO SUPPORT $1BN OFFSHORE OCTG PROJECTS
Meudon (France), on September 11, 2025 – Vallourec, a world leader in premium seamless tubular solutions, has been awarded a major contract by Petrobras as a result of a competitive bidding process for the supply of OCTG (Oil Country Tubular Goods) products and services for its offshore operations from 2026 to 2029. This long-term agreement could generate total revenue of up to USD 1 billion, representing the widest award both in volumes and revenues since Petrobras adopted the open tender strategy.
This contract covers the full OCTG scope of supply for seamless pipes and VAM® premium connections required for Petrobras’ offshore wells from 4.5” up to 18”, including carbon and stainless-steel tubulars and associated accessories. Vallourec will also deliver comprehensive...
Information relating to the total number of voting rights and share capital – August 31, 2025
Written by Customer Service on . Posted in Public Companies.
Disclosure of the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the French Commercial Code and the Article 223-16 of the Règlement général de l’Autorité des marchés financiers   (Regulation of the French stock market authority)
Company name of the issuer:         Renault S.A. 122 – 122 bis Avenue du Général Leclerc 92100 Boulogne-Billancourt
(ISIN code: FR0000131906 – RNO)Date
Total number of issued shares
Total number of voting rightsAugust 31, 2025295,722,284Theoretical number of voting rights (1): 403,545,398Exercisable number of voting rights (2): 397,701,889(1)   Pursuant to Article 223-11 of the Règlement général de l’Autorité des marchés financiers, number calculated on the basis of all shares to which voting rights are attached, including shares for which voting...
